{"id":"pmc:PMC13227393","kind":"review","title":"Efficacy and Safety of Inclisiran—An Assessment of the Consistency Between Randomized Controlled Trials and Real-World Evidence: A Systematic Review","authors":["Lin Y","Wang H","Yang H","Li Z"],"author_count":4,"year":2026,"published":"2026-05-01","venue":"Reviews in cardiovascular medicine","cited_by":0,"doi":null,"arxiv_id":null,"nct_id":null,"source_url":"https://europepmc.org/article/PMC/PMC13227393","archive_url":"https://space-kitty.com/papers/pmc:PMC13227393","updated":null,"pmid":null,"pmcid":"PMC13227393","openalex_id":null,"pdf_url":"https://europepmc.org/articles/PMC13227393/pdf","abstract":null,"abstract_license":null,"license":"CC-BY","is_open_access":true,"retracted":false,"peer_reviewed":null,"categories":[],"details":null,"provenance":"europepmc","attribution":"Metadata: Europe PMC (EMBL-EBI).","topics":[{"slug":"cardiovascular-innovation","name":"Cardiovascular Therapeutics","domain_slug":"medicine"}],"cited_in_dossiers":[]}